- Home
- VCV vs TLRY Comparison
VCV vs TLRY Comparison
Compare VCV & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$3.99
Company Overview
Basic Information| Metric | VCV | TLRY |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.7M | 570.4M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | VCV | TLRY |
|---|---|---|
| Price | $9.73 | $3.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $72.33 |
| AVG Volume (30 Days) | 97.5K | ★ 3.4M |
| Earning Date | 01-01-0001 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.79 |
| Revenue Next Year | N/A | $19.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $0.77 |
| 52 Week High | $11.38 | $15.70 |
Technical Indicators
Market Signals| Indicator | VCV | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 16.19 | 38.64 |
| Support Level | N/A | $3.67 |
| Resistance Level | $10.76 | $4.91 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.06 | -0.07 |
| Stochastic Oscillator | 9.21 | 16.30 |
Price Performance
Historical Comparison VCV
TLRY
About VCV Invesco California Value Municipal Income Trust
Invesco California Value Municipal Income Trust is a closed-end management investment company. Its investment objective is to provide common shareholders with a high level of current income, exempt from federal and California income taxes, consistent with the preservation of capital.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.